Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Jun;81(6):1945–1952. doi: 10.1172/JCI113542

Increased leukotriene B4 synthesis in immune injured rat glomeruli.

M A Rahman 1, M Nakazawa 1, S N Emancipator 1, M J Dunn 1
PMCID: PMC442647  PMID: 2838526

Abstract

We examined glomerular synthesis of the 5-lipoxygenase metabolite, LTB4, in normal and immune-injured rat glomeruli. Glomeruli isolated from normal rats and from rats with nephrotoxic serum nephritis (NSN), passive Heymann nephritis (PHN) and cationic bovine gamma globulin (CBGG)-induced glomerulonephritis were incubated with the calcium ionophore A23187 (3 microM). Lipids in the glomeruli and media were extracted with ethyl acetate, and were purified and fractionated by HPLC. Immunoreactive-LTB4 (i-LTB4) was determined by radioimmunoassay on HPLC fractions with a detection limit of 50 pg of i-LTB4. A large peak of i-LTB4 that comigrated with authentic LTB4 was found exclusively in glomeruli isolated from the CBGG-injected rats. Addition of the lipoxygenase inhibitor BW755C (50 micrograms/ml) to glomerular incubation resulted in greater than 90% inhibition of i-LTB4. Synthesis of i-LTB4 by glomeruli from normal, NSN and PHN rats was undetectable. Glomerular LTB4 synthesis by CBGG-injected rats was confirmed by radiometric HPLC and by gas chromatography mass-spectroscopy (GC-MS) analysis. In order to rule out synthesis of LTB4 by neutrophils entrapped in the glomeruli, a group of rats received 1,000 rad total body x irradiation, with shielding of the kidneys before induction of CBGG glomerulonephritis. Despite greater than 95% reduction in total leukocyte count, glomerular synthesis of LTB4 remained enhanced. Augmented glomerular synthesis of the proinflammatory lipid, LTB4, in the CBGG model of glomerular disease could have an important role in the development of glomerular injury and proteinuria.

Full text

PDF
1949

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badr K. F., Baylis C., Pfeffer J. M., Pfeffer M. A., Soberman R. J., Lewis R. A., Austen K. F., Corey E. J., Brenner B. M. Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Circ Res. 1984 May;54(5):492–499. doi: 10.1161/01.res.54.5.492. [DOI] [PubMed] [Google Scholar]
  2. Barnett R., Goldwasser P., Scharschmidt L. A., Schlondorff D. Effects of leukotrienes on isolated rat glomeruli and cultured mesangial cells. Am J Physiol. 1986 May;250(5 Pt 2):F838–F844. doi: 10.1152/ajprenal.1986.250.5.F838. [DOI] [PubMed] [Google Scholar]
  3. Blair I. A., Brash A. R., Daugherty J., FitzGerald G. A. Quantitative analysis of leukotriene B4 in human serum. Adv Prostaglandin Thromboxane Leukot Res. 1985;15:61–65. [PubMed] [Google Scholar]
  4. Borgeat P., Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci U S A. 1979 May;76(5):2148–2152. doi: 10.1073/pnas.76.5.2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bray M. A., Cunningham F. M., Ford-Hutchinson A. W., Smith M. J. Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol. 1981 Mar;72(3):483–486. doi: 10.1111/j.1476-5381.1981.tb11000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cattell V., Cook H. T., Smith J., Salmon J. A., Moncada S. Leukotriene B4 production in normal rat glomeruli. Nephrol Dial Transplant. 1987;2(3):154–157. [PubMed] [Google Scholar]
  7. Dahlén S. E., Björk J., Hedqvist P., Arfors K. E., Hammarström S., Lindgren J. A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887–3891. doi: 10.1073/pnas.78.6.3887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Danon D., Goldstein L., Marikovsky Y., Skutelsky E. Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res. 1972 Mar;38(5):500–510. doi: 10.1016/0022-5320(72)90087-1. [DOI] [PubMed] [Google Scholar]
  9. Edgington T. S., Glassock R. J., Dixon F. J. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med. 1968 Mar 1;127(3):555–572. doi: 10.1084/jem.127.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  11. Goetzl E. J., Pickett W. C. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol. 1980 Oct;125(4):1789–1791. [PubMed] [Google Scholar]
  12. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979 Jun 15;28(12):1959–1961. doi: 10.1016/0006-2952(79)90651-8. [DOI] [PubMed] [Google Scholar]
  13. Higgs G. A., Salmon J. A., Spayne J. A. The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br J Pharmacol. 1981 Oct;74(2):429–433. doi: 10.1111/j.1476-5381.1981.tb09988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jackson R. M., Chandler D. B., Fulmer J. D. Production of arachidonic acid metabolites by endothelial cells in hyperoxia. J Appl Physiol (1985) 1986 Aug;61(2):584–591. doi: 10.1152/jappl.1986.61.2.584. [DOI] [PubMed] [Google Scholar]
  15. Jim K., Hassid A., Sun F., Dunn M. J. Lipoxygenase activity in rat kidney glomeruli, glomerular epithelial cells, and cortical tubules. J Biol Chem. 1982 Sep 10;257(17):10294–10299. [PubMed] [Google Scholar]
  16. KRAKOWER C. A., GREENSPON S. A. Localization of the nephrotoxic antigen within the isolated renal glomerulus. AMA Arch Pathol. 1951 Jun;51(6):629–639. [PubMed] [Google Scholar]
  17. Kreisle R. A., Parker C. W., Griffin G. L., Senior R. M., Stenson W. F. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response. J Immunol. 1985 May;134(5):3356–3363. [PubMed] [Google Scholar]
  18. Levine L., Morgan R. A., Lewis R. A., Austen K. F., Clark D. A., Marfat A., Corey E. J. Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7692–7696. doi: 10.1073/pnas.78.12.7692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lianos E. A., Andres G. A., Dunn M. J. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest. 1983 Oct;72(4):1439–1448. doi: 10.1172/JCI111100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lianos E. A., Rahman M. A., Dunn M. J. Glomerular arachidonate lipoxygenation in rat nephrotoxic serum nephritis. J Clin Invest. 1985 Oct;76(4):1355–1359. doi: 10.1172/JCI112110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lovett D. H., Sterzel R. B. Cell culture approaches to the analysis of glomerular inflammation. Kidney Int. 1986 Aug;30(2):246–254. doi: 10.1038/ki.1986.176. [DOI] [PubMed] [Google Scholar]
  22. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  23. Morris H. R., Taylor G. W., Piper P. J., Tippins J. R. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature. 1980 May 8;285(5760):104–106. doi: 10.1038/285104a0. [DOI] [PubMed] [Google Scholar]
  24. Murphy R. C., Hammarström S., Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4275–4279. doi: 10.1073/pnas.76.9.4275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nagy L., Lee T. H., Goetzl E. J., Pickett W. C., Kay A. B. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol. 1982 Mar;47(3):541–547. [PMC free article] [PubMed] [Google Scholar]
  26. Nakazawa M., Emancipator S. N., Lamm M. E. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J Exp Med. 1986 Dec 1;164(6):1973–1987. doi: 10.1084/jem.164.6.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rae S. A., Smith M. J. The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4. J Pharm Pharmacol. 1981 Sep;33(9):616–617. doi: 10.1111/j.2042-7158.1981.tb13884.x. [DOI] [PubMed] [Google Scholar]
  28. Rahman M. A., Emancipator S. N., Dunn M. J. Immune complex effects on glomerular eicosanoid production and renal hemodynamics. Kidney Int. 1987 Jun;31(6):1317–1326. doi: 10.1038/ki.1987.145. [DOI] [PubMed] [Google Scholar]
  29. Remuzzi G., Imberti L., Rossini M., Morelli C., Carminati C., Cattaneo G. M., Bertani T. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest. 1985 Jan;75(1):94–101. doi: 10.1172/JCI111703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rokach J., Hayes E. C., Girard Y., Lombardo D. L., Maycock A. L., Rosenthal A. S., Young R. N., Zamboni R., Zweerink H. J. The development of sensitive and specific radioimmunoassays for leukotrienes. Prostaglandins Leukot Med. 1984 Jan;13(1):21–25. doi: 10.1016/0262-1746(84)90098-2. [DOI] [PubMed] [Google Scholar]
  31. Rola-Pleszczynski M., Borgeat P., Sirois P. Leukotriene B4 induces human suppressor lymphocytes. Biochem Biophys Res Commun. 1982 Oct 29;108(4):1531–1537. doi: 10.1016/s0006-291x(82)80081-8. [DOI] [PubMed] [Google Scholar]
  32. Rosenthal A., Pace-Asciak C. R. Potent vasoconstriction of the isolated perfused rat kidney by leukotrienes C4 and D4. Can J Physiol Pharmacol. 1983 Apr;61(4):325–328. doi: 10.1139/y83-049. [DOI] [PubMed] [Google Scholar]
  33. Schreiner G. F., Cotran R. S., Unanue E. R. Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest. 1984 Nov;51(5):524–533. [PubMed] [Google Scholar]
  34. Schreiner G. F., Unanue E. R. Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest. 1984 Nov;51(5):515–523. [PubMed] [Google Scholar]
  35. Serhan C. N., Radin A., Smolen J. E., Korchak H., Samuelsson B., Weissmann G. Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. Biochem Biophys Res Commun. 1982 Aug;107(3):1006–1012. doi: 10.1016/0006-291x(82)90622-2. [DOI] [PubMed] [Google Scholar]
  36. Simonson M. S., Dunn M. J. Leukotriene C4 and D4 contract rat glomerular mesangial cells. Kidney Int. 1986 Oct;30(4):524–531. doi: 10.1038/ki.1986.217. [DOI] [PubMed] [Google Scholar]
  37. Sirois P., Borgeat P., Jeanson A. Comparative effects of leukotriene B4, prostaglandins I2 and E2, 6-keto-PGF1 alpha thromboxane B2 and histamine on selected smooth muscle preparations. J Pharm Pharmacol. 1981 Jul;33(7):466–468. doi: 10.1111/j.2042-7158.1981.tb13836.x. [DOI] [PubMed] [Google Scholar]
  38. Smith M. J., Ford-Hutchinson A. W., Bray M. A. Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol. 1980 Jul;32(7):517–518. doi: 10.1111/j.2042-7158.1980.tb12985.x. [DOI] [PubMed] [Google Scholar]
  39. Spiro R. G. Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem. 1967 Apr 25;242(8):1915–1922. [PubMed] [Google Scholar]
  40. Sraer J., Rigaud M., Bens M., Rabinovitch H., Ardaillou R. Metabolism of arachidonic acid via the lipoxygenase pathway in human and murine glomeruli. J Biol Chem. 1983 Apr 10;258(7):4325–4330. [PubMed] [Google Scholar]
  41. Stenson W. F., Chang K., Williamson J. R. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat. Prostaglandins. 1986 Jul;32(1):5–17. doi: 10.1016/0090-6980(86)90137-1. [DOI] [PubMed] [Google Scholar]
  42. Stork J. E., Dunn M. J. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. J Pharmacol Exp Ther. 1985 Jun;233(3):672–678. [PubMed] [Google Scholar]
  43. Striker G. E., Striker L. J. Glomerular cell culture. Lab Invest. 1985 Aug;53(2):122–131. [PubMed] [Google Scholar]
  44. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES